Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase EARLY_PHASE1 1

Status

Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Gastrointestinal 2Plasma cell 1Other neoplasm 1Other 1Lymphoid 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Hematologic Neoplasms 2Pain, Intractable 1Neoplasms 1Neoplasm Metastasis 1Mucositis 1Leukemia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

venetoclax 304Cyclophosphamide 229Cytarabine 199Azacitidine 187fludarabine 180Specimen Handling 136Biopsy 103fludarabine phosphate 97Methotrexate 81Rituximab 78Daunorubicin 77Dexamethasone 75Vincristine 68Whole-Body Irradiation 64Mycophenolic Acid 59Decitabine 57Tacrolimus 55Etoposide 52ibrutinib 51blinatumomab 51Granulocyte Colony-Stimulating Factor 51Busulfan 50obinutuzumab 49Prednisone 49Melphalan 48acalabrutinib 45Idarubicin 45Stem Cell Transplantation 44Injections 44Magnetic Resonance Spectroscopy 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Morphine × Other hematologic neoplasm × 1 year × Clear all
NCT04188418 2026-02-19

Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
150 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT03579446 2025-08-03

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
43 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡